Cloning and characterization of a mouse σ1 receptor

Journal of Neurochemistry

Volumn 70, Issue 6, 1998, Pages 2279-2285

  Pan, Ying Xian ^a   Mei, Jianfeng ^a   Xu, Jin ^a   Wan, Ban Lin ^a   Zuckerman, Amy ^a   Pasternak, Gavril W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Analgesia; Antiopioid; Antisense; Cloning; Opioid; Pentazocine; receptor

Indexed keywords

PENTAZOCINE; SIGMA OPIATE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHROMOSOME MAP; DRUG RECEPTOR BINDING; GENE ISOLATION; GUINEA PIG; HUMAN; MOLECULAR CLONING; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

ANIMALIA; CAVIA PORCELLUS; MINK CELL FOCUS-FORMING VIRUS; MURINAE; RODENTIA; SUS SCROFA;

EID: 0031799270     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70062279.x     Document Type: Article

References (27)

1. 1 system. Eur. J. Pharmacol. 250, R7-R8.
2. Chien C.-C. and Pasternak G. W. (1994) Selective antagonism of opioid analgesia by a sigma system. J. Pharmacol. Exp. Ther. 271, 1583-1590.
3. Chien C.-C. and Pasternak G. W. (1995a) Sigma antagonists potentiate opioid analgesia in rats. Neurosci. Lett. 190, 137-139.
4. Chien C.-C. and Pasternak G. W. (1995b) (-)-Pentazocine analgesia in mice: interactions with a σ receptor system. Eur. J. Pharmacol. 294, 303-308.
5. 1 receptor ligand. Eur. J. Pharmacol. 321, 361-368.
6. D'Amour F. E. and Smith D. L. (1941) A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72, 174-179.
7. Gutstein H. B., Bronstein D. M., and Akil H. (1992) β-Endorphin processing and cellular origins in rat spinal cord. Pain 51, 241-247.
8. 1-binding site. Proc. Natl. Acad. Sci. USA 93, 8072-8077.
9. Heng H. H. Q., Squire J., and Tsui L.-C. (1992) High resolution mapping mammalian genes by in situ hybridization to free chromatin. Proc. Natl. Acad. Sci. USA 89, 9509-9513.
10. Hylden J. L. K. and Wilcox G. L. (1980) Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67, 313-316.
11. John C. S., Bowen W. D., Varma V. M., McAfee J. G., and Moody T. W. (1995) Sigma receptors are expressed in human non-small cell lung carcinoma. Life Sci. 56, 2385-2392.
12. Kawabata A., Nishimura Y., and Takagi H. (1992) L-Leucyl-L-arginine, naltrindole and D-arginine block antinociception elicited by L-arginine in mice with carrageenin-induced hyperalgesia. Br. J. Pharmacol. 107, 1096-1101.
13. Kekuda R., Prasad P. D., Fei Y.-J., Leibach F. H., Ganapathy V., and Fei Y. J. (1996) Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem. Biophys. Res. Commun. 229, 553-558.
14. Kiefel J. M., Cooper M. L., and Bodnar R. J. (1992) Serotonin receptor subtype antagonists in the medial ventral medulla inhibit mesencephalic opiate analgesia. Brain Res. 597, 331-338.
15. King M. A., Pan Y.-X., Mei J., Chang A., Xu J., and Pasternak G. W. (1997) Enhanced kappa opioid analgesia by antisense targeting the σ1 receptor. Eur. J. Pharmacol. 331, R5-R7.
16. Kolesnikov Y. A., Pan Y. X., Babey A. M., Jain S., Wilson R., and Pasternak G. W. (1997) Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance. Proc. Natl. Acad. Sci. USA 94, 8220-8225.
17. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
18. Luke M. C., Hahn E. F., Price M., and Pasternak G. W. (1988) Irreversible opiate agonists and antagonists: V. Hydrazone and acylhydrazone derivatives of naltrexone. Life Sci. 43, 1249-1256.
19. 3-related opioid receptor. Mol. Pharmacol. 47, 1180-1188.
20. Pasquini F., Bochet P., Garbay-Jaureguiberry C., Roques B. P., Rossier J., and Beaudet A. (1992) Electron microscopic localization of photoaffinity-labelled delta opioid receptors in the neostriatum of the rat. J. Comp. Neurol. 326, 229-244.
21. Pasternak G. W. and Standifer K.M. (1995) Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. Trends Pharmacol. Sci. 16, 344-350.
22. Pick C. G., Nejat R., and Pasternak G. W. (1993) Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains. J. Pharmacol. Exp. Ther. 2265, 166-171.
23. Quirion R., Bowen W. D., Itzhak Y., Junien J. L., Musacchio J. M., Rothman R. B., Su T.-P., Tam S. W., and Taylor D. P. (1992) A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13, 85-86.
24. Rossi G. C., Pan Y.-X., Brown G. P., and Pasternak G. W. (1995) Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6β-glucuronide receptor. FEBS Lett. 369, 192-196.
25. 1 binding in a human neuroblastoma cell line. Neurochem. Res. 21, 1309-1314.
26. Standifer K. M., Chien C.-C., Wahlestedt C., Brown G. P., and Pasternak G. W. (1994) Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor. Neuron 12, 805-810.
27. Walker J. M., Bowen W. D., Walker F. O., Matsumoto R. R., De Costa B., and Rice K. C. (1990) Sigma receptors: biology and function. Pharmacol. Rev. 42, 355-402.